Bio-Rad Laboratories, Inc.

Bio-Rad Laboratories develops, manufactures, and sells a wide range of instruments, test kits, and reagents used in biomedical research and clinical diagnostics. A core segment of its product portfolio includes tools and assays specifically designed for, and marketed to, animal research and preclinical testing applications. This includes instruments like the Biolistic® Particle Delivery System for genetically transforming animal cells, as well as test kits for animal disease screening, such as for BSE and chronic wasting disease. The company is routinely listed alongside major pharmaceutical and contract research organizations in market analyses of the global animal testing and non-animal alternative testing industry, indicating its established role as a supplier to this research chain.

While Bio-Rad's products enable research conducted by other entities, its business model is materially dependent on the animal testing market. The company is explicitly cited by ethical screening sources, such as Cruelty Free Investing, for producing and selling analytical instruments and products for life science research that involves animal use. This positions Bio-Rad as a provider of essential tools for animal testing, even if it does not conduct the tests in its own facilities.